Overall, initial neuroimaging evidence in human samples supports the hypothesis of activity-dependent Aβ and tau production, particularly in the early stages of Alzheimer’s disease. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.